BEOVU — 1900271

Toolbar

Details

Application number

1900271

Registration number

TMA1072372

Type(s)

Word

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2018-05-22

Registered

2020-02-11

Registration Expiry Date

2030-02-11

Registrant

NOVARTIS AG
4002 BASEL
SWITZERLAND

Agent

SMART & BIGGAR LP
1100-150 York Street
TORONTO
ONTARIO M5H3S5

Documents

Index headings

  • BEOVU
  • BEO VU
  • VIEW

Goods (Nice class & Statement)

5
(1) Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals.

Claims

  • Proposed Use in CANADA

Action History

Actions
Action Action date Due date Comments
Filed 2018-05-22
Created 2018-05-23
Formalized 2018-05-28
Search Recorded 2019-09-05
Examiner's First Report 2019-09-05 2020-03-05
Agent Name Changed 2019-09-11
Approved 2019-10-01
Approval Notice Sent 2019-10-01
Advertised 2019-10-09 Vol.66 Issue 3389
Registration Pending 2020-01-01
Registration Fee Notice Sent 2020-01-01 2020-07-01
Registered 2020-02-11 2030-02-11
Federal Court Proceeding Initiated 2022-08-24 Date initiated: 2022/08/10
Date modified: